GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FHN · Mar 31, 2023

FIRST HORIZON CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000036966-23-000048Bank
Sequential deposit growth15thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-3.23% · CORE · VALID

Net-income growth65thOwn-history percentile · N=17
Evidence method

Yoy · gp.fundamentals.net_income

28.72% · CORE · VALID

Interest-expense growth100thOwn-history percentile · N=17
Evidence method

Yoy · gp.financial.interest_expense

648.39% · CORE · VALID

Cash and equivalents21thOwn-history percentile · N=14
Evidence method

Level · gp.fundamentals.cash

$1.3B · CORE · VALID

Sequential loan growth63thOwn-history percentile · N=16
Evidence method

Sequential · gp.financial.loans

1.59% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History31 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-3.83%
Current
-3.23%
Delta
0.60%
Earnings Growth Increased
Previous
-9.91%
Current
28.72%
Delta
38.63%
Funding Cost Growth Increased
Previous
77.44%
Current
648.39%
Delta
570.95%
Liquidity Decreased
Previous
$1.5B
Current
$1.3B
Delta
-$247.0M
Loan Growth Increased
Previous
1.28%
Current
1.59%
Delta
0.31%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.